Patent:
United States Patent 5,407,944
Goldman Apr. 18, 1995
Inventors:
Goldman; Boris E. (2019 Breton, S.E., Grand Rapids, MI 49546).
Appl. No:
020,202
Filed:
Feb. 19, 1993
Abstract:
The present invention provides compositions and methods for promoting hair growth. The methods generally comprise the administration to a patient of a therapeutically effective amount of the compositions of the present invention which employ a vasodilator in combination with estradiol and/or a 5-.alpha.-reductase inhibitor in a pharmaceutically acceptable vehicle. The compositions and methods of the present invention are suitable for the treatment of baldness, in particular, male pattern baldness.
36 Claims, 4 Drawing Figures
References Cited:
U.S. Patent Documents
4,596,812 Jun, 1986 Chidsey, III et al. 514/256
5,015,470 May, 1991 Gibson 424/70
Other References
Hamilton, J. B., “Male Hormone Stimulation is Prerequisite and an Incitant in Common Baldness.” Am J. Anat. 71:451-480 (1942).
Jonsson, K. et al., “Tissue Oxygenation, Anemia, and Perfusion in Relation to Wound Healing in Surgical Patients,” Ann. Surg. 214, 5:605-613 (1991).
Bruchovsky, N. et al., “The Conversion of Testosterone to 5 .alpha.-Androstan-17 .beta.-ol-3-one Rat Prostate in Vivo and in Vitro*,” J. Biol. Chem. 243:2012 (1968).
Fang, S. et al., “Receptor Proteins for Androgens,” J. Biol. Chem. 244:6584 (1969).
Thigpen, A. E. et al., “Tissue Distribution and Ontogeny of Steroid 5 Alpha-Redustase Isozyme Expression,” J. Clin. Invest. 92(2):903-10 (1993).
Mellin, T. N. et al., “Azasteroids as Inhibitors of Testosterone 5 Alpha-Redustase in Mammalian Skin,” J. Steroid Biochem. Mol. Biol. 44(2):121-31 (1993).
Imperato-McGinley, J. et al., “The Androgen Control of Sebum Production. Studies of Subjects with Dihydrotestosterone Deficiency and Complete Androgen Insensitivity,” J. Clin. Endocrinol. Metab. 76(2):524-8 (1993).
Diani, A. R. et al., “Hair Growth Effects of Oral Administration of Finasteride, a Steroid 5 Alpha-Reductase Inhibitor, Alone and in Combination with Topical Minoxidil in the Balding Stumptail Macaque,” J. Clin. Endocrinol. Metab. 74(2):345-50 (1992).
Young, M. W., “American Association of Anatomists,” Anatomical Record 100:728 (1948).
Young, M. W., “American Association of Anatomists,” Anatomical Record 97:378 (1947).
Szasz, T. S. et al. “A Theory of the Pathogenesis of Ordinary Human Baldness” Archives of Dermatology and Syphilology 61:34-48 (1950).
Orentreich, N. “Autografts in Alopecias and Other Selected Dermatological Conditions,” Ann. NY Acad. Sci. 83:463-479 (1959).
Orentreich, N. et al. “Biology of Scalp Hair Growth,” Clin. Plast. Surg. 9:197:205 (1982).
Zapocosta, A. R. “Reversal of Baldness in Patient Receiving Minoxidil for Hypertension,” New Eng. J. Med. 303:1480-1481 (1980).
Hamilton, J. B. “Patterned Loss of Hair in Man: Types and Incidence,” Ann. NY Acad. Sci. 53:709:728 (1951).
Klemp. P. et al., “Subcutaneous Blood Flow in Early Male Pattern Baldness,” J. Invest. Derm. 92(5):725-726 (1989).
Juri, J. et al. “Temporo-Parieto-Occipital Flap for the Treatment of Baldness,” Clin. Plas. Surg. 9:255-261 (1982).
Lemke, R. et al., “Noninvasive Ptco(2) Initial Slope Index and Invasive Ptco(2) Arterial Index as Diagnostic Criterion of the State of Peripheral Circulation,” Crit. Care Med. 16:353-357 (1988).
Kram, H. B. et al., “Assessment of Peripheral Vascular Disease by Postocclusive Transcutaneous Oxygen Recovery Time,” J. Vasc. Surg. 1:628-634 (1984).
Wester, R. C. et al., “Minoxidil Stimulates Cutaneous Blood Flow in Human Balding Scalps: Pharmacodynamics Measured by Laser Doppler Velocimetry and Photopulse Plethysmography,” J. Invest. Derm. 82:515-517 (1984).
Dingman, R. O. et al., “The Surgical Repair of Traumatic Defects of the Scalp,” Clin. Plast. Surg. 9:131-144 (1982).
Hunt, et al., “The Effect of Varying Ambient Oxygen Tensions on Wound Metabolism and Collagen Synthesis,” Surg. Gyn. Ob. 135:561-566 (1972).
Marshall, R. C. et al., “Structure and Biochemistry of Mammalian Hard Keratin,” 4:47-83 (1991).
Buxman, M. et al., “Keratin Cross-Linking and Epidermal Transglutaminase,” J. Invest. Derm. 65:107-112 (1975).
Buxman, M. M., “Enzymes of Keratinization,” Internat. J. Derm. 20:95-98 (1981).
Sawaya, M. E. et al., “Immunohistochemical Distribution of Aromatase and 3B-hydroxysteroid Dehydrogenase in Human Hair Follicle and Sebaceous Gland,” J. Cutan. Pathol. 19:309-314 (1992).
Sawaya, M. E. “Steroid Chemistry and Hormone Controls During the Hair Follicle Cycle,” Ann. NY Acad. Sci. 642:376-383 (1991) and (Abstract).
Schweikert, H. U. et al., “Regulation of Human Hair Growth by Steroid Hormones. 1. Testosterone Metabolism in Isolated Hairs,” J. Clin. Endocrin. Metab. 38:811-819 (1974).
Orfanos, C. E. “Lokaltherapie der Alopecia Androgentica mit 17 .alpha.-Ostradiol,” Dermatologica 161:124-132 (1980).
Takayasu, S. et al., “The Conversion of Testosterone to 17.beta.-hydroxy-5.alpha.-androstan-3-one (Dihydrotestosterone) by Human Hair Follicles,” J. Clin. Endocrinol. Metab. 34:1098 1101(1972).
Anderson, R. D., “Expansion-Assisted Treatment of Male Pattern Baldness,” Clin. Plast. Surg. 14:477-489 (1987).
Herring, B. D., “Unravelling the Pathophysiology of Male Pattern Baldness,” J. Nation. Med. Assoc. 77:142 and 145 (1985).
Freedberg, I. M., “Biochemistry of Keratinization in Hair: Protein Synthesis, Pathways and Controls,” pp. 105-112 (1987).
Hamilton, J. B., Am. J. Anat. 71:451-480 (1942).
Tang, S. et al., J. Biol. Chem. 244:6584 (1969).
Primary Examiner: Prescott; Arthur C.
Attorney, Agent or Firm: Harness, Dickey & Pierce
